All posts by : MOPartAdmin

Abbott rival Mylan gets FDA approval for generic hypertension drug

Mylan Inc. said Tuesday that the Food and Drug Administration approved the drugmaker’s generic version of the high blood pressure treatment Teveten. more ... Read More

Missouri’s tax climate receives high rankings from the Tax Foundation

A new study by the Tax Foundation showed that Missouri’s tax climate is better than all surrounding states. Missouri ranked 16th overall for the fourth year in a row. The state ... Read More

Information technology services company to expand operations in Springfield

JMARK Business Solutions Inc., a company that specializes in the management and maintenance of the IT infrastructure for its business customers, announced plans to expand its headquarters, a capital investment of ... Read More

Obama Administration confirms $30 billion Boeing F-15 deal

Eighty four F-15 fighter jets, which are built at Boeing’s facility in Hazelwood, are being sold to Saudi Arabia at a cost of $30 billion, according to the Obama administration. The ... Read More

U.S. Military boosts investment in algae fuels

The forest green algae bubbling in a stainless steel fermenting tank in a suburban warehouse may look like primordial pond scum, but it is a promising new source of domestically produced ... Read More

Boeing lands $3.5 billion missile defense contract

The U.S. Defense Department has awarded Boeing Co. a $3.48 billion, seven-year contract to develop, test, engineer and manufacture missile defense systems, the Chicago Tribune reports. Boeing beat out a team ... Read More

Kauffman: MU is commercialization leader

The Ewing Marion Kauffman Foundation has named the University of Missouri System as one of three universities that are “Kauffman Commercialization Leaders.” The Kansas City-based foundation said Wednesday that the MU ... Read More

Bristol-Myers to pay $2.5 billion for Inhibitex

Bristol-Myers Squibb has agreed to pay about $2.5 billion in cash to acquire Inhibitex, the New York Times reports. Inhibitex makes a treatment for hepatitis C. The move comes as large ... Read More

Innovative sports information technology company to expand operations in Kansas City

Sporting Innovations, a company that creates web software to enrich the experience of sports fans, including mobile applications, announced plans to expand operations in Kansas City. The company plans to make ... Read More

Stowers group nears start on giant biotech park in south Kansas City

A massive biotech office park in south Kansas City long planned by James Stowers III is finally ready to move forward. A pending land swap with the city will give Stowers ... Read More